Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6156463

NC(=O)c1ccc(OC2CCNCC2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 3/20 0.60
CHEK2 O96017 5/20 0.54
SENP8 Q96LD8 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
HRH1 P35367 2/20 0.50
MAP4K4 O95819 1/20 0.49
FAAH O00519 1/20 0.48
EPHX2 P34913 1/20 0.48
KCNH2 Q12809 2/20 0.44
OPRK1 P41145 1/20 0.44
NEK2 P51955 1/20 0.42
PARP15 Q460N3 2/20 0.41
PARP2 Q9UGN5 1/20 0.41
GRK6 P43250 1/20 0.41
F10 P00742 2/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
PARP14 Q460N5 1/20 0.40
PARP16 Q8N5Y8 1/20 0.40
PARP11 Q9NR21 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4629826 1.00 PARP10 (0.60) PARP10CHEK2SENP8SENP6HRH1
SCHEMBL4798997 0.90 PARP10 (0.73) PARP10CHEK2SENP8SENP6HRH1
Hydrochloric Acid SCHEMBL3636392 0.89 PARP10 (0.71) PARP10CHEK2SENP8SENP6HRH1
Trifluoroacetic Acid SCHEMBL23830909 0.86 PARP10 (0.55) PARP10SENP8SENP6MAP4K4FAAH
Trifluoroacetic Acid SCHEMBL2823895 0.83 HRH1 (0.53) PARP10CHEK2HRH1EPHX2KCNH2
SCHEMBL3133910 0.81 PARP10 (0.64) PARP10CHEK2SENP8SENP6MAP4K4
Trifluoroacetic Acid SCHEMBL4233307 0.81 EPHX2 (0.50) HRH1EPHX2KCNH2
Hydrochloric Acid SCHEMBL3127575 0.80 PARP10 (0.62) PARP10CHEK2SENP8SENP6MAP4K4
SCHEMBL4241025 0.79 HRH1 (0.62) PARP10CHEK2SENP8SENP6HRH1
Trifluoroacetic Acid SCHEMBL6703422 0.79 HTR2C (0.51) PARP10OPRK1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3440052-B1 COMPOUNDS FOR USE IN THE TREATMENT OF CANCER UNIV OF OULU (FI) 2023-10-25 EP disclosed
US-20210346322-A1 Compounds for use in the treatment of cancer UNIVERSITY OF OULU (FI) 2021-11-11 US disclosed
US-20190105289-A1 Compounds for use in the treatment of cancer UNIVERSITY OF OULU (FI) 2019-04-11 US disclosed
EP-3440052-A1 COMPOUNDS FOR USE IN THE TREATMENT OF CANCER University Of Oulu (FI) 2019-02-13 EP disclosed
WO-2017174879-A1 COMPOUNDS FOR USE IN THE TREATMENT OF CANCER UNIVERSITY OF OULU (FI) 2017-10-12 WO disclosed
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210346322-A1 Compounds for use in the treatment of cancer PARP10, MACROD1, MACROD2 PARP10 1/4885CHEK2 2431/4885SENP8 4775/4885
US-20190105289-A1 Compounds for use in the treatment of cancer PARP10, MACROD1, MACROD2 PARP10 1/4885CHEK2 2431/4885SENP8 4775/4885
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 PARP10 1211/4885CHEK2 2711/4885SENP8 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.